Piper Sandler analyst Brent Bracelin reiterates Adobe (NASDAQ:ADBE) with a Overweight and maintains $415 price target.
Canaccord Genuity Maintains Buy on Evolent Health, Lowers Price Target to $48
Canaccord Genuity analyst Richard Close maintains Evolent Health (NYSE:EVH) with a Buy and lowers the price target from $55 to $48.